C. Mayerhofer

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.

T. Ueland, M. Kummen, J. Hov, 2018, Journal of the American College of Cardiology.

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

S. Halvorsen, P. Aukrust, J. Hov, 2018, ESC heart failure.

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure.

T. Ueland, P. Aukrust, J. Hov, 2017, Journal of cardiac failure.

Lesion Complexity and€Prolonged Antiplatelet Therapy

T. Ueland, M. Kummen, J. Hov, 2018 .

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.

G. Dellgren, K. Karason, T. Ueland, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

T. Ueland, A. Svardal, P. Aukrust, 2020, ESC heart failure.

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

S. Halvorsen, A. Svardal, P. Aukrust, 2021, EBioMedicine.